ARTICLE | Distillery Therapeutics
Neurology
October 18, 2018 6:44 PM UTC
Cell culture and mouse studies suggest inhibiting CASP1 could help treat AD. In primary human neurons overexpressing APP, a tool compound CASP1 inhibitor decreased axon degeneration compared with no t...
BCIQ Company Profiles